摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-二甲基喹喔啉-2-胺 | 35552-76-2

中文名称
N,N-二甲基喹喔啉-2-胺
中文别名
N,N-二甲基-2-喹喔啉胺
英文名称
2-Dimethylamino-chinoxalin
英文别名
2-Dimethylaminoquinoxalin;dimethyl-quinoxalin-2-yl-amine;quinoxalin-2-yl-dimethyl-amine;Chinoxalin-2-yl-dimethyl-amin;N,N-dimethylquinoxalin-2-amine
N,N-二甲基喹喔啉-2-胺化学式
CAS
35552-76-2
化学式
C10H11N3
mdl
——
分子量
173.217
InChiKey
ZOWBRYALCDNHPV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    29
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    2-氯喹恶啉二甲胺 在 [2-(di-tert-butylphosphino)-2′,4′,6′-triisopropyl-1,1′-biphenyl][2-((2-aminoethyl)phenyl)]palladium(II) chloride 、 lithium hexamethyldisilazane 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以88%的产率得到N,N-二甲基喹喔啉-2-胺
    参考文献:
    名称:
    Simple, efficient protocols for the Pd-catalyzed cross-coupling reaction of aryl chlorides and dimethylamine
    摘要:
    Simple and efficient Procedures for the Pd-catalyzed cross-coupling reaction of aryl chlorides and dimethylamine are described. At room temperature with a Strong base, t-BuXPhos is employed as the supporting ligand; at 110 degrees C with a weak base, XPhos is employed as the supporting ligand. In each of these cases, commercially available solutions constitute the source of the dimethylamine, and recently disclosed precatalysts constitute the source of the ligand and Pd. This work further expands the utility of these precatalysts in reactions that benefit from an easily activated source of L,Pd(0). (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2009.03.137
点击查看最新优质反应信息

文献信息

  • Room‐Temperature Dialkylamination of Chloroheteroarenes Using a Cu(II)/PTABS Catalytic System
    作者:Harshita Shet、Manisha Patel、Jyoti M. Waikar、Pavan M. More、Yogesh S. Sanghvi、Anant R. Kapdi
    DOI:10.1002/asia.202201006
    日期:2023.1.3
    relevant molecules and methodologies to install these efficiently are highly desirable. We report herein a highly efficient, room-temperature dimethylamination of chloroheteroarenes performed via the in-situ generation of dimethylamine using N,N-dimethylformamide (DMF) as precursor with a large substrate scope that includes various heteroarenes, purines as well as commercially relevant drugs such as
    二甲氨基功能在工业相关分子中具有重要意义,因此非常需要有效安装这些分子的方法。我们在此报告了使用N,N-二甲基甲酰胺 (DMF) 作为前体,通过原位生成二甲胺进行的代杂芳烃的高效室温二甲胺化,底物范围广泛,包括各种杂芳烃嘌呤以及商业相关药物如六甲胺吡嗪嘌呤霉素前体。
  • ORGANIC COMPOUNDS CONTAINING SILICON OR GERMANIUM, TRANSITION METAL COMPLEXES, CATALYST FOR $g(a)-OLEFIN POLYMERIZATION, AND PROCESSES FOR PRODUCING $g(a)-OLEFIN POLYMERS
    申请人:MITSUBISHI CHEMICAL CORPORATION
    公开号:EP0985674A1
    公开(公告)日:2000-03-15
    An alkali metal- or alkali earth metal-containing organic compound (i) is reacted with a leaving group- and silicon- or germanium-containing compound (ii) in the presence of a nitrogen-containing aromatic heterocyclic compound. By such a method, it is possible to produce a silicon- or germanium-containing organic compound, for example, a cyclopentadienyl compound cross-linked by a silicon atom or a germanium atom, typically a cyclopentadienyl compound which is substituted with a substituted or unsubstituted silyl or germyl group, for a short time with a high yield.
    含碱属或碱土属的有机化合物(i)在含氮芳香杂环化合物存在下与离去基团和含的化合物(ii)反应。通过这种方法,可以在短时间内以高产率生产出含的有机化合物,例如,由原子或原子交联的环戊二烯基化合物,通常是由取代或未取代的基或基取代的环戊二烯基化合物。
  • ORGANIC COMPOUNDS CONTAINING SILICON OR GERMANIUM, TRANSITION METAL COMPLEXES, CATALYST FOR ALPHA-OLEFIN POLYMERIZATION, AND PROCESSES FOR PRODUCING ALPHA-OLEFIN POLYMERS
    申请人:MITSUBISHI CHEMICAL CORPORATION
    公开号:EP0985674B1
    公开(公告)日:2003-04-23
  • PHARMACEUTICAL COMPOUNDS
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:US20210107908A1
    公开(公告)日:2021-04-15
    The invention provides new pyrazine derivatives of formula (I): or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein. The invention also provides pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
  • US6255515B1
    申请人:——
    公开号:US6255515B1
    公开(公告)日:2001-07-03
查看更多